Headlands Technologies’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.3M Buy
77,266
+54,534
+240% +$2.96M 0.35% 70
2026
Q1
$1.43M Sell
22,732
-2,911
-11% -$233K 0.16% 137
2025
Q4
$2.45M Sell
25,643
-82,403
-76% -$8.08M 0.2% 108
2025
Q3
$10.5M Buy
108,046
+60,091
+125% +$6.22M 0.84% 21
2025
Q2
$5.15M Buy
47,955
+28,473
+146% +$2.88M 0.62% 33
2025
Q1
$1.97M Buy
+19,482
New +$1.96M 0.22% 113
2024
Q3
Sell
-8,335
Closed -$642K 1213
2024
Q2
$642K Sell
8,335
-6,790
-45% -$497K 0.07% 232
2024
Q1
$1.04M Buy
+15,125
New +$972K 0.25% 104

Other funds holding BSX

Headlands Technologies's BSX Position: Q2 2026 in Review

Headlands Technologies increased its Boston Scientific (BSX) stake by 240% in Q2 2026, buying an estimated $2.96M and bringing the position to 77,266 shares worth $3.3M. The position accounts for 0.35% of the portfolio, ranked #70.

Headlands Technologies first reported a position in BSX in Q1 2024 and has held it in 8 quarters since. The position peaked at $10.5M in Q3 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Headlands Technologies held 77,266 shares of Boston Scientific worth $3.3M as of Q2 2026.
  • Headlands Technologies bought 54,534 Boston Scientific shares in Q2 2026, an estimated $2.96M.
  • Boston Scientific made up 0.35% of Headlands Technologies's portfolio in Q2 2026, its #70 holding.
  • Headlands Technologies first reported a position in Boston Scientific in Q1 2024 and has held it in 8 quarters since.
  • Headlands Technologies's Boston Scientific position peaked at $10.5M in Q3 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.